ARMN Pharma's End-to-End Solution for Healthcare in Haryana

ARMN Pharmaceutical Private Limited is set to initiate a transformative project in Panipat, Haryana, focused on Bulk Drug & Bulk Drug Intermediates Manufacturing. With an estimated cost of Rs. 12.03 Crores and a production capacity of 113.6 MT/Annum Bulk Drug, the project signifies a significant investment in the pharmaceutical sector.

While the specific types of bulk drugs and intermediates to be manufactured by ARMN Pharma are not available at the moment, this information can be researched for a more comprehensive understanding of the project. Additionally, exploring the environmental impact assessment and any planned mitigation measures will provide insights into the project's commitment to sustainability.

The job creation potential of the Bulk Drug & Bulk Drug Intermediates Manufacturing project can be estimated based on similar endeavors in the pharmaceutical industry. This assessment would shed light on the positive economic impact the project is likely to have on the region, contributing to employment opportunities and fostering local development. As more details unfold, the ARMN Pharma project in Panipat holds the promise of not only bolstering the pharmaceutical landscape but also contributing to the socio-economic growth of the surrounding community.

As on January, 2024. Project has gotten approvals. All approvals were granted. By March 2024, project construction will begin.

News by Rahul Yelligetti